NCT07019493 Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke
| NCT ID | NCT07019493 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Florey Institute of Neuroscience and Mental Health |
| Condition | Stroke Patients |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-07-19 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-07-19 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Investigators are running a small, early-phase research study across several hospitals in Melbourne, Australia. The study will involve up to 100 young adults between the ages of 18 and 55 who have had a stroke. The goal is to test how practical it is to carry out a detailed health assessment process-called "deep phenotyping"-with this group. This process involves collecting a wide range of information and samples from stroke survivors to better understand each participant's condition. The Investigators will look at how well this approach works in practice, including how easy it is to use, whether it's done consistently, and how acceptable it is to participants. At the same time, the Investigators will also explore how different factors-such as biological markers (biomarkers), age, sex, type of stroke, lifestyle, and environment-might be related to stroke recovery. This pilot study will prepare for larger studies in the future.
Eligibility Criteria
Inclusion Criteria: 1. Between 18 and 55 years. 2. Within one month of acute stroke confirmed with standard of care brain imaging or clinical diagnosis or for those for whom recruitment \<1 month of stroke is not possible they may be recruited to participate within 3-months of stroke Exclusion Criteria: 1. Severe, intercurrent or progressive illness likely to EITHER 1. Have a prognosis for survival under 24 months; OR 2. In the opinion of the investigator will mask the importance to the individual participant data (e.g. severe MS, dementia, etc) 2. Major psychiatric condition requiring medical intervention
Contact & Investigator
Vincent Thijs, MD, PhD
PRINCIPAL INVESTIGATOR
Florey Institute of Neuroscience and Mental Health
Frequently Asked Questions
Who can join the NCT07019493 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Stroke Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07019493 currently recruiting?
Yes, NCT07019493 is actively recruiting participants. Contact the research team at emily.ramage@florey.edu.au for enrollment information.
Where is the NCT07019493 trial being conducted?
This trial is being conducted at Heidelberg, Australia, Heidelberg, Australia.
Who is sponsoring the NCT07019493 clinical trial?
NCT07019493 is sponsored by The Florey Institute of Neuroscience and Mental Health. The principal investigator is Vincent Thijs, MD, PhD at Florey Institute of Neuroscience and Mental Health. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.